PL2380586T3 - Oligopeptydy R-Lys-X jako materiał do powlekania wyrobów medycznych - Google Patents

Oligopeptydy R-Lys-X jako materiał do powlekania wyrobów medycznych

Info

Publication number
PL2380586T3
PL2380586T3 PL10075581T PL10075581T PL2380586T3 PL 2380586 T3 PL2380586 T3 PL 2380586T3 PL 10075581 T PL10075581 T PL 10075581T PL 10075581 T PL10075581 T PL 10075581T PL 2380586 T3 PL2380586 T3 PL 2380586T3
Authority
PL
Poland
Prior art keywords
oligopeptides
lys
coating material
medical products
medical
Prior art date
Application number
PL10075581T
Other languages
English (en)
Inventor
Erika Hoffmann
Michael Hoffmann
Roland Horres
Original Assignee
Hemoteq Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemoteq Ag filed Critical Hemoteq Ag
Publication of PL2380586T3 publication Critical patent/PL2380586T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Paints Or Removers (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10075581T 2003-10-07 2004-10-05 Oligopeptydy R-Lys-X jako materiał do powlekania wyrobów medycznych PL2380586T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/680,035 US20090232866A1 (en) 2003-10-07 2003-10-07 Oligopeptides as coating material for medical products
EP04765826A EP1670502A2 (en) 2003-10-07 2004-10-05 Oligopeptides as coating material for medical products
EP10075581.8A EP2380586B1 (en) 2003-10-07 2004-10-05 R-Lys-X Oligopeptides as coating material for medical products

Publications (1)

Publication Number Publication Date
PL2380586T3 true PL2380586T3 (pl) 2015-12-31

Family

ID=34520532

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10075581T PL2380586T3 (pl) 2003-10-07 2004-10-05 Oligopeptydy R-Lys-X jako materiał do powlekania wyrobów medycznych

Country Status (15)

Country Link
US (1) US20090232866A1 (pl)
EP (2) EP1670502A2 (pl)
JP (1) JP4861182B2 (pl)
KR (1) KR20070019947A (pl)
CN (1) CN1889974B (pl)
AU (1) AU2004283427B8 (pl)
CA (1) CA2542913C (pl)
EA (1) EA010499B1 (pl)
ES (1) ES2549389T3 (pl)
IL (1) IL174603A (pl)
MX (1) MXPA06003889A (pl)
NZ (1) NZ546315A (pl)
PL (1) PL2380586T3 (pl)
WO (1) WO2005039629A2 (pl)
ZA (1) ZA200603110B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8367108B2 (en) 2006-09-01 2013-02-05 Bezwada Biomedical, Llc Functionalized non-phenolic amino acids and absorbable polymers therefrom
HUE040417T2 (hu) 2007-05-04 2019-03-28 Marina Biotech Inc Aminosavlipidek és alkalmazásuk
KR101792032B1 (ko) * 2008-12-19 2017-11-02 백스터 인터내셔널 인코포레이티드 Ｔｆｐｉ 억제제 및 사용 방법
DK2547355T3 (en) 2010-03-19 2017-03-20 Baxalta GmbH TFPI INHIBITORS AND METHODS OF USE
JP2015508406A (ja) * 2012-01-03 2015-03-19 ルーイ・ジェイ・ユ Ｎ−アシルペプチド誘導体およびそれらの使用
BR112014022435B1 (pt) 2012-03-21 2023-02-14 Takeda Pharmaceutical Company Limited Inibidores de tfpi e métodos de uso
CN106730049B (zh) * 2016-12-22 2020-05-12 深圳汉诺医疗科技有限公司 一种生物相容性内置支架材料
CN113521286B (zh) * 2020-07-20 2023-08-18 中国医学科学院基础医学研究所 冠状病毒蛋白酶抑制剂及其应用
CN117143183B (zh) * 2023-08-25 2024-08-16 广州益养生物科技有限公司 一种三肽、三肽盐或衍生物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890546B2 (en) * 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
JP4767418B2 (ja) * 1999-03-24 2011-09-07 エムエスエイチ ファーマ，インコーポレイテッド アルファ−メラノサイト−刺激ホルモン由来の抗菌性アミノ酸配列
US6355618B1 (en) * 1999-04-09 2002-03-12 Cytovia, Inc. Caspase inhibitors and the use thereof
DE19950386A1 (de) * 1999-10-19 2001-05-10 Miladin Lazarov Biokompatibler Gegenstand
WO2001058526A2 (en) * 2000-02-10 2001-08-16 Alexion Pharmaceuticals, Inc. Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
CA2444518A1 (en) * 2001-04-17 2002-10-24 University Of Sheffield Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
EP1432432A4 (en) * 2001-09-05 2005-09-07 Inc Zengen CANCER TREATMENT SYSTEM
CN1568166A (zh) * 2001-10-15 2005-01-19 荷姆泰克股份有限公司 预防再狭窄的涂层支架
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
ATE504311T1 (de) * 2002-01-16 2011-04-15 Capstone Therapeutics Corp Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur
IL163771A0 (en) * 2002-02-28 2005-12-18 Novartis Ag N-ä5-Ä4-(4-methyl-piperazino-methyl benzoylamidoÜ--2-methylphenylü-4-(3-pyridyl)-2-pyrimidine-amine coated stents
US7361339B2 (en) * 2003-01-09 2008-04-22 Alexion Pharmaceuticals, Inc. Methods for reducing morality associated with acute myocardial infarction

Also Published As

Publication number Publication date
HK1097746A1 (en) 2007-07-06
EA200600549A1 (ru) 2006-10-27
CN1889974B (zh) 2012-08-29
CA2542913C (en) 2015-01-06
AU2004283427B2 (en) 2008-12-11
EA010499B1 (ru) 2008-10-30
IL174603A0 (en) 2006-08-20
KR20070019947A (ko) 2007-02-16
EP1670502A2 (en) 2006-06-21
AU2004283427B8 (en) 2009-01-29
EP2380586B1 (en) 2015-07-15
JP4861182B2 (ja) 2012-01-25
NZ546315A (en) 2009-06-26
EP2380586A3 (en) 2012-01-04
CA2542913A1 (en) 2005-05-06
US20090232866A1 (en) 2009-09-17
WO2005039629A3 (en) 2005-06-23
AU2004283427A1 (en) 2005-05-06
EP2380586A2 (en) 2011-10-26
ES2549389T3 (es) 2015-10-27
IL174603A (en) 2010-12-30
MXPA06003889A (es) 2006-08-11
WO2005039629A2 (en) 2005-05-06
JP2007507264A (ja) 2007-03-29
ZA200603110B (en) 2007-12-27
CN1889974A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
GB0315457D0 (en) Biological products
EP1615615A4 (en) PHARMACEUTICAL PRODUCTS
GB0303337D0 (en) Biological products
GB0412181D0 (en) Biological products
GB0225279D0 (en) Biological products
GB0305133D0 (en) Product
GB0224082D0 (en) Biological products
TWI345977B (en) Pharmaceutical products comprising bisphosphonates
GB0325836D0 (en) Biological products
GB0312148D0 (en) Stabilized pharmaceutical products
GB0315889D0 (en) Stable pharmaceutical products
EP1516897A4 (en) WATER-BASED COATING MATERIAL FOR RUBBER ARTICLE
IL174603A0 (en) Oligopeptides as coating material for medical products
AU2003264541A1 (en) Medical material
EP1681325A4 (en) COATING MATERIALS
GB0314901D0 (en) Coating material
GB2405853B (en) Material handling
GB0316360D0 (en) Pharmaceutical product
GB0317475D0 (en) Product
GB2447190B (en) Trihalomethionine derivative and pharmaceutical product containing the same
GB0320836D0 (en) Material
GB0319588D0 (en) Biological products
PL365363A1 (pl) Wyrób złotniczy
GB0327181D0 (en) Biological products
GB0313252D0 (en) Biological products